A detailed history of Engineers Gate Manager LP transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 50,718 shares of STRO stock, worth $177,513. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,718
Previous 80,570 37.05%
Holding current value
$177,513
Previous $455,000 67.47%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.92 - $5.33 $87,167 - $159,111
-29,852 Reduced 37.05%
50,718 $148,000
Q1 2024

May 15, 2024

BUY
$3.27 - $5.65 $78,447 - $135,543
23,990 Added 42.4%
80,570 $455,000
Q4 2023

Feb 14, 2024

BUY
$2.07 - $4.54 $117,120 - $256,873
56,580 New
56,580 $242,000
Q1 2023

May 15, 2023

SELL
$4.48 - $8.45 $22,055 - $41,599
-4,923 Reduced 21.15%
18,355 $84,000
Q4 2022

Feb 14, 2023

BUY
$5.41 - $8.08 $18,870 - $28,183
3,488 Added 17.63%
23,278 $188,000
Q3 2022

Nov 14, 2022

BUY
$5.17 - $7.11 $102,314 - $140,706
19,790 New
19,790 $110,000
Q2 2022

Aug 15, 2022

SELL
$3.41 - $8.95 $47,058 - $123,509
-13,800 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.78 - $15.31 $107,364 - $211,278
13,800 New
13,800 $113,000
Q3 2021

Nov 15, 2021

SELL
$16.88 - $22.38 $244,760 - $324,510
-14,500 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$18.03 - $23.82 $261,435 - $345,390
14,500 New
14,500 $270,000
Q1 2021

May 17, 2021

SELL
$20.29 - $27.54 $395,370 - $536,644
-19,486 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$10.16 - $23.98 $197,977 - $467,274
19,486 New
19,486 $423,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $183M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.